| MUC17 altered in cohorts of …ALTERED_INderived24 of 24show fewer |
|---|
| → altered in cohorts of | Skin Basal Cell Carcinoma 66 / 126 cases (52 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 139 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 41 / 144 cases (28 %) · ssm · mel_dfci_2019 · largest of 2 cohorts | — | — | Melanoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Pancreatic Adenocarcinoma 21 / 93 cases (23 %) · ssm · paad_iatlas_prince_2022 | — | — | Pancreatic Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Small Cell Carcinoma 27 / 120 cases (23 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 111 / 566 cases (20 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 8 cohorts | — | — | Lung Adenocarcinoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 219 / 1,144 cases (19 %) · ssm · nsclc_tcga_broad_2016 | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 29 / 158 cases (18 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 80 / 484 cases (17 %) · ssm · lusc_tcga_gdc · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 60 / 518 cases (12 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 27 / 247 cases (11 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 20 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 65 / 629 cases (10 %) · ssm · difg_glass · largest of 6 cohorts | — | — | Diffuse Glioma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 30 / 291 cases (10 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 47 / 478 cases (9.8 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 41 / 429 cases (9.6 %) · ssm · coad_tcga_gdc | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 41 / 474 cases (8.6 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 39 / 494 cases (7.9 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 38 / 515 cases (7.4 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 33 / 499 cases (6.6 %) · ssm · prad_tcga · largest of 2 cohorts | — | — | Prostate Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 57 / 1,015 cases (5.6 %) · ssm · crc_sysucc_2022 · largest of 3 cohorts | — | — | Colorectal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | High-Grade Serous Ovarian Cancer 21 / 405 cases (5.2 %) · ssm · hgsoc_tcga_gdc | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | cbioportal | graph → |